NCT03868917

Brief Summary

Posterolateral thoracotomies are among the most painful procedures of surgery and may cause severe postoperative chest pain and impaired respiratory performance. Paravertebral block (PVB) is an established method of administering postoperative analgesia for thoracic procedures. PVB blocks the somatic and sympathetic nervous systems and is placed by injecting a local anesthetic (LA) into the paravertebral space where the nerve and its branches are located after exiting the intervertebral foramen. But previous study showed 5-10% of failure rate in PVB using ultrasound machine. Pressure measurement during needle advancement could improve reliability of correct needle placement. When the needle tip reaches paravertebral space, there is a sudden lowering of pressures due to respiratory cycle. Therefore, sensitivity and specificity could be improved and correct needle placement become objective and reproducible when PVB using ultrasound is combined with pressure measurement during needle advancement.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 11, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

March 14, 2019

Status Verified

March 1, 2019

Enrollment Period

12 months

First QC Date

March 6, 2019

Last Update Submit

March 12, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • visual analogue scale for pain (VAS) at 2 hour after the arrival of postanesthetic care unit (PACU)

    VAS score is measured at 2 hour after a patient arrives in PACU. The pain VAS is a unidimensional measure of pain intensity. The pain VAS is a continuous scale comprised of a horizontal (HVAS) line, usually 10 centimeters (100 mm) in length, anchored by 2 verbal descriptors, one for each symptom extreme (no pain 0, maximal pain 100).

    2 hour after the arrival of PACU

Study Arms (2)

ultrasound group

NO INTERVENTION

The participants have continuous thoracic paravertebral block performed using only the ultrasound approach.

pressure measurement group

EXPERIMENTAL

The participants have continuous thoracic paravertebral block performed using the ultrasound-guided approach combined with pressure measurement techniqueduring needle advancement.

Procedure: thoracic paravertebral block using pressure measurement technique

Interventions

The continuous thoracic paravertebral block using ultrasound machine is combined with pressure measurement during needle advancement.

pressure measurement group

Eligibility Criteria

Age19 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled for elective thoracotomy
  • ASA status 1,2

You may not qualify if:

  • Inability to provide adequate informed consent
  • Any contraindication to the placement of thoracic paravertebral catheters
  • Unstable vertebral and transverse process fractures
  • Any chronic painful conditions or preoperative opioid use Any chronic painful conditions or preoperative opioid use
  • Coagulation abnormalities or expectation to be on therapeutic anticoagulants postoperatively
  • Allergy to any of the drugs/agents used in study protocol
  • Altered mental status or emergency surgery
  • Comorbid conditions such as sepsis, unstable angina, congestive heart failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Pain Medicine, Yeungnam University hospital

Daegu, 705-035, South Korea

RECRUITING

Related Publications (2)

  • Syal K, Chandel A. Comparison of the post-operative analgesic effect of paravertebral block, pectoral nerve block and local infiltration in patients undergoing modified radical mastectomy: A randomised double-blind trial. Indian J Anaesth. 2017 Aug;61(8):643-648. doi: 10.4103/ija.IJA_81_17.

  • Zupcic M, Graf Zupcic S, Duzel V, Simurina T, Sakic L, Fuduric J, Persec J, Milosevic M, Stanec Z, Korusic A, Barisin S. A combination of levobupivacaine and lidocaine for paravertebral block in breast cancer patients undergoing quadrantectomy causes greater hemodynamic oscillations than levobupivacaine alone. Croat Med J. 2017 Aug 31;58(4):270-280. doi: 10.3325/cmj.2017.58.270.

Study Officials

  • SANGJIN PARK, MD

    Yeungnam University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

SANGJIN PARK, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Each participant is randomized to one of two groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

March 6, 2019

First Posted

March 11, 2019

Study Start

January 2, 2019

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

March 14, 2019

Record last verified: 2019-03

Locations